The accusation that I am antisemitic is appalling and fundamentally dishonest. Criticizing the actions of the Israeli prime minister, a military technology contract, or the executives who supply it is not the same as criticizing Jewish people. This critical and necessary dialogue is then dishonestly framed as being anti-Israel. To be clear, my views come from my own political convictions and should never be interpreted as hostility toward Jewish people, for whom I have deep love and respect. Everything I know about acting, activism, and humanism has been profoundly shaped by the Jewish friends, colleagues, and loved ones who have been integral and family throughout every point of my life.
This merger has real consequences for real people, and for the entire country. Scrutinizing the Ellisons, including Oracle’s business built on data, surveillance technology and government contracts, and the serious threat to editorial freedom and the loss of a livelihood for thousands of families, is fair and necessary. The $111 billion deal would hand one family control over CNN, HBO and Warner Bros., backed in part by foreign money whose influence on editorial decisions has never been fully explained to the public.
Lawmakers on both sides of the aisle have called for serious national security review, and regulators still haven’t given the public a real answer. Until they do, the merger shouldn’t move forward. Now is the time to dive boldly into all these issues, not step back or concede.
My mom passed away from breast cancer when I was 14 years old. What I remember most is how much work it was just to be sick. Referrals were made and forgotten, every new doctor meant starting over, and my family was left to fill in the gaps because the healthcare system never carried that weight for us.
I started Amigo because there are too many stories like mine.
We build, train, and deploy AI agents that can safely deliver care across clinical use cases such as intake and triage, chronic care management, and 24/7 virtual care.
AI is transforming every industry it touches, but healthcare has a higher bar. There's no room for errors or hallucinations, and definitely no second chances with patient lives. That's the problem no one in this space has solved.
We asked ourselves “how do you make AI safe enough to deliver care?” The answer was obvious: clinical agents need to be trained the same way we train doctors.
So we pioneered the industry's first Digital Residency program, training every AI agent against millions of simulated patient cases until they reach a 100% safety pass rate.
And it’s working.
In just the last six months, Amigo agents have completed over 3 million patient encounters around the world with zero safety incidents.
I'm proud to announce that Amigo has raised $17M to make healthcare work for everyone, including our $11M Series A led by Madrona with participation from Optum Ventures, General Catalyst, and GSV Ventures.
We have a real chance to build something better together. For healthcare organizations thinking about how AI can safely expand the reach of their care teams, I'd love to talk.